Combination of nivolumab and ipilimumab

Combination of nivolumab and ipilimumab
Trade Name
Orphan Indication Metastatic Melanoma
USA Market Approval USA
USA Designation Date 2014-10-09 00:00:00
Sponsor Bristol-Myers Squibb Company;5 Research Parkway;Wallingford, Connecticut, 06492
Related Access Program
Merck Sharp & Dohme Corp. – Metastatic Melanoma Eli Lilly and Company – Metastatic Melanoma Bristol-Myers Squibb – Metastatic Melanoma Bristol-Myers Squibb – Metastatic Melanoma